Moreover, both the level of phosphorylated S6 protein (Fig. 2d) and immunoreactivity (Fig. 2e, f) were markedly increased in the region of the lesion in this RHEB mutation carrier compared to non-FCD controls. This evidence concerns the gene RHEB and fleck corneal dystrophy.